Netflix reaffirmed its dominance among streamers in 2024, closing the year with 301.6 million memberships, a robust 16% ...
Flow chemistry is the development and study of chemical reactions whereby reactants are combined by pumping fluids, including solutions of reagents, through tubes at known rates. The relative ...
PayPal (NASDAQ: PYPL) has taken it on the chin over the past several years. The digital payment company has struggled to ...
High Tide reports fourth-quarter revenue of 138.3 million Canadian dollars ($95.9 million), missing analyst estimates. "We are witnessing an accelerating rate of growth in our membership program ...
Rapid7, Inc. faces significant challenges with rising debt, activist investor pressure, and a competitive market, raising concerns about its financial stability and growth prospects. Despite ...
Complete the form below to receive the latest headlines and analysts' recommendations for Meta Platforms with MarketBeat's free daily email newsletter: ...
Competition is intense, and some businesses are likely to go bankrupt. In such a context, Stratasys (NASDAQ:SSYS) remains the market leader with innovative products. It has launched material cost ...
Xerox Q4 2024 revenue declined 8.6% YoY to $1.613B, topping estimates, but adjusted EPS missed at $0.36 vs. $0.53 expected. Equipment sales dropped 14.2%, gross margin fell 240 bps to 31.1%, and ...
Cava Group (NYSE: CAVA) stock was a breakout winner last year as the market cap of the Mediterranean fast-casual restaurant chain more than doubled on blistering growth. The numbers the company is ...
Maze Therapeutics begins Phase 2 trial for kidney disease drug By Investing.com - Feb 07, 2025 SOUTH SAN FRANCISCO – Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical ...
Suffice it to say that, as a customer, I'm a fan of Airbnb. Despite my clear enthusiasm for the brand, I haven't invested in ...
Crossmark Global Holdings Inc. decreased its stake in Domino’s Pizza, Inc. (NASDAQ:DPZ – Free Report) by 13.9% during the 4th quarter, according to the company in its most recent disclosure ...